Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study
Álex Iranzo, Graham Fairfoul, Anutra Chumbala Na Ayudhaya, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 3, pp. 203-212
Open Access | Times Cited: 247

Showing 1-25 of 247 citing articles:

Challenges in the diagnosis of Parkinson's disease
Eduardo Tolosa, Alícia Garrido, Sonja W. Scholz, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 5, pp. 385-397
Open Access | Times Cited: 1030
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 5, pp. 407-417
Open Access | Times Cited: 379
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
Tanya Simuni, Lana M. Chahine, Kathleen L. Poston, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 178-190
Closed Access | Times Cited: 251
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria
Günter U. Höglinger, Charles H. Adler, Daniela Berg, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 191-204
Closed Access | Times Cited: 239
Neuropathology and molecular diagnosis of Synucleinopathies
Shunsuke Koga, Hiroaki Sekiya, Naveen Kondru, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 208
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder
Mitchell G. Miglis, Charles H. Adler, Elena Antelmi, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 8, pp. 671-684
Open Access | Times Cited: 172
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
Marco J. Russo, Christina D. Orrú, Luis Concha‐Marambio, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 171
Propagative α-synuclein seeds as serum biomarkers for synucleinopathies
Ayami Okuzumi, Taku Hatano, Gen Matsumoto, et al.
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1448-1455
Open Access | Times Cited: 164
Multiple system atrophy
Werner Poewe, Iva Stanković, Glenda M. Halliday, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 161
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
Ilaria Poggiolini, Vandana Ayyar Gupta, Michael Lawton, et al.
Brain (2021) Vol. 145, Iss. 2, pp. 584-595
Open Access | Times Cited: 125
Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid
Luis Concha‐Marambio, Sandra Pritzkow, Mohammad Shahnawaz, et al.
Nature Protocols (2023) Vol. 18, Iss. 4, pp. 1179-1196
Open Access | Times Cited: 121
Clinical and imaging evidence of brain-first and body-first Parkinson's disease
Jacob Horsager, Karoline Knudsen, Michael Sommerauer
Neurobiology of Disease (2022) Vol. 164, pp. 105626-105626
Open Access | Times Cited: 99
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies
G. Bellomo, Chiara Maria Giulia De Luca, Federico Paolini Paoletti, et al.
Neurology (2022) Vol. 99, Iss. 5, pp. 195-205
Closed Access | Times Cited: 98
Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
Pedro Magalhães, Hilal A. Lashuel
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 96
Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease
Sara Hall, Christina D. Orrú, Geidy E. Serrano, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 73
Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study
Stephen Joza, Joshua Shulman, Ki‐Young Jung, et al.
Brain (2023) Vol. 146, Iss. 8, pp. 3258-3272
Closed Access | Times Cited: 70
Circadian disruption and sleep disorders in neurodegeneration
Yun Shen, Qian‐Kun Lv, Wei-Ye Xie, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 65
Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder
Álex Iranzo, Angela Mammana, Amaia Muñoz‐Lopetegi, et al.
Neurology (2023) Vol. 100, Iss. 18
Open Access | Times Cited: 63
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Thomas Koeglsperger, S Rumpf, Patricia Schließer, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 62
Proposal for a Biologic Staging System of Parkinson’s Disease
Lana M. Chahine, Kalpana Merchant, Andrew Siderowf, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 3, pp. 297-309
Open Access | Times Cited: 59
Accurate Detection of α‐Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort
Luis Concha‐Marambio, Sandrina Weber, Carly M. Farris, et al.
Movement Disorders (2023) Vol. 38, Iss. 4, pp. 567-578
Open Access | Times Cited: 58
α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis
Anna Grossauer, Greta Hemicker, Florian Krismer, et al.
Movement Disorders Clinical Practice (2023) Vol. 10, Iss. 5, pp. 737-747
Open Access | Times Cited: 57
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden
Giuseppe Mario Bentivenga, Angela Mammana, Simone Baiardi, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 37
Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay
G. Bellomo, Andrea Toja, Federico Paolini Paoletti, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2444-2452
Open Access | Times Cited: 35
Detecting Misfolded α‐Synuclein in Blood Years before the Diagnosis of Parkinson's Disease
Annika Kluge, Eva Schaeffer, Josina Bunk, et al.
Movement Disorders (2024) Vol. 39, Iss. 8, pp. 1289-1299
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top